Very few drugs utilized frequently in audiological medicine have undergone rigorous methodological testing to prove their efficacy. The employment of drugs on patients with dizziness, tinnitus, Meniére's disease or sudden sensorineural hearing loss is determined by empirical not scientific premises. Recent progress in genetics, molecular biology and neurobiology raises expectations that a breakthrough will be made before long for the treatment of certain audiological pathologies. While we are keen to see this progress delivered, we need to proceed with caution in the face of the proposed advances.
New drugs, new tests: Can we trust them?
BOVO, Roberto;MARTINI, Alessandro
2006
Abstract
Very few drugs utilized frequently in audiological medicine have undergone rigorous methodological testing to prove their efficacy. The employment of drugs on patients with dizziness, tinnitus, Meniére's disease or sudden sensorineural hearing loss is determined by empirical not scientific premises. Recent progress in genetics, molecular biology and neurobiology raises expectations that a breakthrough will be made before long for the treatment of certain audiological pathologies. While we are keen to see this progress delivered, we need to proceed with caution in the face of the proposed advances.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
